Article
Dundee, Scotland - A routine cell culture of a patient with epidermolysis bullosa simplex (EBS) has led to the inadvertent discovery of a revertant mutation that deactivates the original pathogenic mutation, according to Irwin McLean, Ph.D.
Reviewing Major Dermatologic Studies of the Year: 2024
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Dermatology Times 2024 In Review: Acne
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
2024 Dermatology Conferences Recap: Part 2
Dermatology Times 2024 In Review: Hidradenitis Suppurativa